Close this search box.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) Post Treatment Lyme Disease Syndrome (PTLDS), Fibromyalgia Leading Research. Delivering Hope.Open Medicine Foundation® Canada

OMF Adds a Fourth ME / CFS Collaborative Research Center


We are pleased to announce that we have added a fourth ME / CFS Collaborative Research Center (CRC) to join our End ME / CFS Project.

Directed by Alain Moreau, PhD, the ME / CFS Collaborative Research Center at CHU Sainte-Justine/Université de Montréal in Québec, Canada will serve to increase our international collaborative efforts.

Dr. Moreau and his lab have been researching Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) for several years. After meeting Ronald W. Davis, PhD, OMF Scientific Advisory Board Director, and OMF CEO Linda Tannenbaum in 2017, Dr. Moreau has been a part of the ME / CFS working group and has presented multiple times at the community symposium held at Stanford University. Additionally, he organized the first ME / CFS Canadian Collaborative Conference held in Montreal in May 2018.

“I initially decided to invite Dr. Moreau to join our ME / CFS Working Group because he demonstrated that he could take multiple novel approaches to understand the disease. His work will be very complementary to the research of other investigators. The CRC in Montreal extends our international collaboration for solving ME / CFS.” Ronald W. Davis, PhD

About the Research

The new ME / CFS Collaborative Research Center at the Université de Montréal is searching for the cause of the disease with a focus on actionable therapeutic targets. Their innovative research program is at the frontier of genetic predisposition and external factors that may have altered the gene expression in ME / CFS patients (epigenetic changes).

They hope that monitoring different biomarker changes during a stress test will shed light on the pathophysiology of ME / CFS and help to identify specific molecular signatures. In parallel, they intend to develop better clinical tools allowing clinicians to diagnose ME / CFS and select the best treatments to address their medical needs. Ultimately, they hope to find a cure to end ME / CFS.


Dr. Moreau’s Research Team at the ME / CFS Collaborative Research Center CHU Sainte-Justine/Université de Montréal in Québec, Canada

Learn more about the ME / CFS Collaborative Research Center, Université de Montréal

About Dr. Moreau

Alain Moreau, PhD, is a Full Professor in the Department of Stomatology, Faculty of Dentistry and Department of Biochemistry and Molecular Medicine, Faculty of Medicine, at Université de Montréal, Montréal, Québec, Canada. Additionally, Dr. Moreau is the Director of Network for Canadian Oral Health Research. He is the Scientific Director of the Viscogliosi Laboratory in Molecular Genetics of Musculoskeletal Diseases, Sainte-Justine University Research Center, Montréal, Québec.

Dr. Moreau’s chief interests of study are pediatric scoliosis, osteoarthritis, osteoporosis, and Myalgic Encephalomyelitis. Dr. Moreau is a member of the Open Medicine Foundation Scientific Advisory Board and is the Director of the Interdisciplinary Canadian Collaborative Myalgic Encephalomyelitis Research Network, a national research network funded by the Canadian Institute of Health Research.


We are so proud of the great minds from across the globe that have joined The End ME / CFS Project. Dr. Moreau’s colleagues are from Canada, France, Iran, Moldova, China, Egypt, Columbia, Spain, Russia, and Romania!